A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
IFLScience on MSN1h
Montana Considers Becoming First US State To Ban mRNA Vaccine UseOn Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz with ...
AZoLifeSciences on MSN2h
High-Resolution Images Reveal How Cells Discard Faulty SpliceosomesA sophisticated molecular machine, the spliceosome, ensures the accurate assembly of genetic information from the genome into ...
A new class of lipids developed by Penn Engineers improve the rates at which lipid nanoparticles (LNPs) successfully deliver ...
Northwestern Medicine scientists have uncovered new details explaining how poxviruses manipulate host cells to enhance their ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
For 2025, Lonza expects strong performance in its CDMO business with CER sales growth approaching 20% and CORE EBITDA margin approaching 30%. Excluding Vacaville, which is expected to contribute ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about ...
Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking w.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback